Holen Sie sich die Stockscreener-App
2.53
4.12%
0.10
Handel nachbörslich:
2.42
-0.11
-4.35%
Finanzdaten der Syros Pharmaceuticals Inc-Aktie (SYRS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
0.386 | 3.762 | 2.833 | 2.954 |
Operating Expenses
|
12.33%
30.92
|
27.53 | 38.40 | 36.83 | 36.17 |
| Interest Income/Expense |
1.66%
1.307
|
1.329 | 1.303 | 1.278 | 1.217 |
| Operating Income/Loss |
13.93%
-30.92
|
-27.14 | -34.64 | -34.00 | -33.21 |
| Income/Loss From Continuing Operations Before Tax |
103.37%
-3.708
|
110.13 | 3.762 | 2.833 | -23.79 |
| Income/Loss From Continuing Operations After Tax |
94.24%
-3.708
|
-64.38 | -40.14 | -36.26 | -23.79 |
|
Net Income/Loss
|
94.24%
-3.708
|
-64.38 | -40.14 | -36.26 | -23.79 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
9,411%
38.98
|
0.4098 | 27.99 | 27.91 | 27.84 |
| Diluted Average Shares |
9,411%
38.98
|
0.4098 | 27.99 | 27.91 | 27.84 |
| Basic Earnings Per Share |
95.50%
-0.10
|
-2.22 | -1.43 | -1.30 | -0.85 |
| Diluted Earnings Per Share |
95.50%
-0.10
|
-2.22 | -1.43 | -1.30 | -0.85 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.02%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):